NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Hims & Hers Health
HIMS
5
Tempus AI
TEM
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 4,849.39%3.35B | -25.76%633.59M | ||||||||
Net income from continuing operations | ---- | ---- | ---- | ---- | ---- | 1,757.85%1.95B | 56.07%475.44M | ---- | ---- | ---- |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | 67.34%-26.66M | -157.51%-17.57M | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | 3.19%14.09B | -1.82%3.33B | ---- | ---- | ---- |
Deferred tax | ---- | ---- | ---- | ---- | ---- | -103.35%-1.01M | 73.65%-224K | ---- | ---- | ---- |
Other non cash items | ---- | ---- | ---- | ---- | ---- | 56.77%-313.02M | 116.69%33.04M | ---- | ---- | ---- |
Change In working capital | ---- | ---- | ---- | ---- | ---- | 7.83%-13.36B | -8.80%-3.4B | ---- | ---- | ---- |
-Change in receivables | ---- | ---- | ---- | ---- | ---- | -123.95%-86.74M | -39.49%201.86M | ---- | ---- | ---- |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | -115.68%-34.88M | 122.09%112.92M | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | 97.69%-76.74M | 85.36%-52.12M | ---- | ---- | ---- |
-Change in other current assets | ---- | ---- | ---- | ---- | ---- | -3.88%-6.38B | -137.67%-1.66B | ---- | ---- | ---- |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | -101.75%-17.92M | -5.82%111.38M | ---- | ---- | ---- |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | -1.86%-6.76B | 70.34%-2.11B | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -37.04%2.11B | -61.72%242.52M | -70.81%242.52M | -53.62%410.75M | -6.39%937.77M | 4,849.39%3.35B | -25.76%633.59M | 324.42%830.69M | 1,769.89%885.56M | 185.84%1B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -754.00%-1.74B | -347.13%-1.43B | ||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | 78.78%-36.97M | -118.53%-19.23M | ---- | ---- | ---- |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | 28.87%-67.94M | 29.78%-19.98M | ---- | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | -138.64%-186.8M | -89.64%62.63M | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | -2,864.11%-1.45B | -12,824.73%-1.45B | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -40.55%-2.44B | -16.22%-1.66B | -2,909.62%-1.66B | 179.97%336.26M | -233.51%-222.76M | -754.00%-1.74B | -347.13%-1.43B | -113.58%-55.25M | 35.55%-420.48M | 347.89%166.85M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -195.89%-4.29B | -100.79%-22.48M | ||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | -389.27%-7.68B | -100.14%-4.16M | ---- | ---- | ---- |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | 87.65%3.39B | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | 34.70%69.84M | 111.29%5.67M | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -54.58%-68.53M | 62.64%-24M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 68.03%-1.37B | -11,515.24%-2.61B | -1,070.16%-2.61B | 173.68%865.89M | 107.78%261.14M | -195.89%-4.29B | -100.79%-22.48M | 354.25%269.19M | -252.48%-1.18B | -264.01%-3.36B |
Net cash flow | ||||||||||
Beginning cash position | -32.83%5.28B | 28.96%7.91B | 55.58%7.91B | 10.71%6.27B | -32.83%5.28B | 155.67%7.86B | 71.45%6.13B | 68.32%5.08B | 45.89%5.66B | 155.67%7.86B |
Current changes in cash | 36.22%-1.7B | -391.95%-4.03B | -485.95%-4.03B | 327.15%1.61B | 144.61%976.15M | -157.31%-2.67B | -119.09%-819.53M | 110.32%1.04B | 24.34%-710.07M | -369.40%-2.19B |
Effect of exchange rate changes | -84.08%14.66M | -166.52%-83.81M | -1,927.08%-83.81M | -81.91%23.11M | 264.82%14.61M | -24.82%92.04M | -266.66%-31.45M | -92.38%4.59M | 70.13%127.76M | -106.86%-8.86M |
End cash Position | -32.01%3.59B | -28.19%3.79B | -38.16%3.79B | 55.58%7.91B | 10.71%6.27B | -32.83%5.28B | -32.83%5.28B | 71.45%6.13B | 68.32%5.08B | 45.89%5.66B |
Free cash flow | -35.01%2.11B | -59.20%242.52M | -86.15%115.03M | -53.62%410.75M | -6.39%937.77M | 1,053.96%3.25B | -27.17%594.38M | 324.42%830.69M | 1,769.89%885.56M | 185.84%1B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |